OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128 | -36.0% | 40,485 | +4.8% | 0.00% | – |
| Q2 2023 | $200 | -1.0% | 38,639 | +0.9% | 0.00% | – |
| Q1 2023 | $202 | +71.2% | 38,295 | -8.5% | 0.00% | – |
| Q4 2022 | $118 | -99.9% | 41,861 | +35.5% | 0.00% | – |
| Q3 2022 | $129,000 | +24.0% | 30,889 | +19.2% | 0.00% | – |
| Q2 2022 | $104,000 | +6.1% | 25,908 | +31.2% | 0.00% | – |
| Q1 2022 | $98,000 | +6.5% | 19,741 | +48.9% | 0.00% | – |
| Q4 2021 | $92,000 | -73.4% | 13,260 | -61.6% | 0.00% | – |
| Q3 2021 | $346,000 | -29.5% | 34,560 | -0.3% | 0.00% | – |
| Q2 2021 | $491,000 | -9.1% | 34,660 | +5.3% | 0.00% | – |
| Q1 2021 | $540,000 | +0.6% | 32,901 | +26.9% | 0.00% | – |
| Q4 2020 | $537,000 | – | 25,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |